Physician profile
Richard Johnson
NPI 1740691765
$1,391.90
in general payments reported to CMS, 2019-2025
12 companies · $509 in 2025
The $509 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $158 · 2024: $725 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812 · Travel and Lodging: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $812.04 |
| Travel and Lodging | $422.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $698.51 | 2024 | Ligasure, Endo Gia Ultra, Signia |
| Integra Lifesciences Corporation | $191.01 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Atricure, INC. | $157.69 | 2022 | |
| Boston Scientific Corporation | $145.74 | 2025 | Spyglass |
| Acera Surgical, INC. | $41.96 | 2024-2025 | Restrata Wound Matrix |
| Ethicon US, LLC | $26.32 | 2025 | Enseal |
| W. L. Gore & Associates, INC. | $23.75 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Takeda Pharmaceuticals U.S.A., INC. | $23.30 | 2025 | Entyvio |
| Intuitive Surgical, INC. | $23.00 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $21.00 | 2025 | Exparel |
| Dilon Technologies, INC. | $20.54 | 2025 | Hemoblast Bellows |
| Intercept Pharmaceuticals, INC. | $19.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.